[go: up one dir, main page]

MX9203735A - Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso. - Google Patents

Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.

Info

Publication number
MX9203735A
MX9203735A MX9203735A MX9203735A MX9203735A MX 9203735 A MX9203735 A MX 9203735A MX 9203735 A MX9203735 A MX 9203735A MX 9203735 A MX9203735 A MX 9203735A MX 9203735 A MX9203735 A MX 9203735A
Authority
MX
Mexico
Prior art keywords
drug
supply
therapeutic agent
use environment
dose form
Prior art date
Application number
MX9203735A
Other languages
English (en)
Inventor
Atul D Ayer
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/019,989 external-priority patent/US4810502A/en
Priority claimed from US07/310,167 external-priority patent/US4915952A/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX9203735A publication Critical patent/MX9203735A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9203735A 1987-02-27 1992-06-29 Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso. MX9203735A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/019,989 US4810502A (en) 1987-02-27 1987-02-27 Pseudoephedrine brompheniramine therapy
US07/310,167 US4915952A (en) 1987-02-27 1989-02-15 Composition comprising drug, HPC, HPMC and PEO
US07/498,791 US5023076A (en) 1987-02-27 1990-03-26 Lamina comprising carboxyvinyl polymer

Publications (1)

Publication Number Publication Date
MX9203735A true MX9203735A (es) 1992-09-01

Family

ID=27361338

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203735A MX9203735A (es) 1987-02-27 1992-06-29 Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.

Country Status (2)

Country Link
US (1) US5023076A (es)
MX (1) MX9203735A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
IE70735B1 (en) * 1994-08-15 1996-12-11 Elan Med Tech Orally administrable delivery device
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4457907A (en) * 1982-08-05 1984-07-03 Clear Lake Development Group Composition and method for protecting a therapeutic drug
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4662880A (en) * 1986-03-14 1987-05-05 Alza Corporation Pseudoephedrine, brompheniramine therapy
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties

Also Published As

Publication number Publication date
US5023076A (en) 1991-06-11

Similar Documents

Publication Publication Date Title
MX9203560A (es) Una forma de dosis para surtir pseudoefedrina.
AR240399A1 (es) Dispositivo suministrador para administrar una formulacion de agente beneficioso a un ambiente de uso.
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
NL190664B (nl) Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten.
FI940787L (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
IT8667657A0 (it) Nante dispositivo erogatore per la sommi nistrazione di un agente benefico all ambiente d uso particolarmente per la somministrazione di un agente terapeutico ad un animale rumi
ES537022A0 (es) Un procedimiento para la preparacion de una formulacion medicamentosa para inyeccion intravenosa.
IT1182253B (it) Dispositivo ad azione osmotica per la somministrazione di un agente benefico all ambiente circostante particolarmente per la somministrazione di farmaci in ambito gastrointe stinale
IT1128094B (it) Catetere per la somministrazione en dovenosa intermittente di medicamenti
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
ES508185A0 (es) Un procedimiento para preparar una composicion farmaceutica en forma de dosis mitarica.
MX9203556A (es) Una forma de dosificacion para administrar los farmacos beneficos pseudoefedrina y bromofeniramina.
MX174161B (es) Una forma de dosis para suministrar el farmaco benefico verapamil
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
MX9203559A (es) Una forma de dosificacion para administrar clorofeniramina.
ES277844Y (es) Una disposicion de punta de dosificacion para administrar una dosis de medicamento, alimentos, vitaminas o similares, a un paciente
FI883381A7 (fi) Terapeutiska medel.
MX174157B (es) Forma de dosis para suministrar diltiazen
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
MX9200532A (es) Agente farmaceuticos.
FI901876A0 (fi) Ofullstaendiga hepadnavirus, vaccin producerande cellinjer samt terapi av leversjukdomar.
IT1179843B (it) Dispositivo osmotico e procedimento per l erogazione di un agente benefico particolarmente di un farmaco ad un ambiente d uso
MX9203782A (es) Forma de dosis con capacidad de administracion mejorada.
ES541370A0 (es) Un procedimiento para la preparacion de una composicion de etoposido en forma de dosis unitaria para administracion oral